PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 7.53

Change

+0.12 (+1.62)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.05 (+0.17%)

USD 9.17B
QLD ProShares Ultra QQQ

-1.47 (-1.34%)

USD 7.84B
FNGU MicroSectors FANG+ Index 3X Le..

-17.37 (-2.93%)

USD 7.31B
SSO ProShares Ultra S&P500

-0.36 (-0.38%)

USD 5.60B
UPRO ProShares UltraPro S&P500

-0.52 (-0.57%)

USD 4.27B
TECL Direxion Daily Technology Bull..

-2.17 (-2.42%)

USD 3.10B
YINN Direxion Daily FTSE China Bull..

N/A

USD 1.32B
USD ProShares Ultra Semiconductors

-1.38 (-2.06%)

USD 1.16B
UDOW ProShares UltraPro Dow30

-0.48 (-0.49%)

USD 0.91B
LABU Direxion Daily S&P Biotech Bul..

-1.89 (-2.24%)

USD 0.82B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.06% 64% D 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.06% 64% D 87% B+
Trailing 12 Months  
Capital Gain 0.40% 20% F 34% F
Dividend Return 1.04% 47% F 15% F
Total Return 1.44% 20% F 24% F
Trailing 5 Years  
Capital Gain -72.76% 18% F 5% F
Dividend Return 1.01% 16% F 3% F
Total Return -71.74% 18% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 57.69% 79% B- 94% A
Dividend Return 58.25% 79% B- 94% A
Total Return 0.56% 41% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 392.92% 15% F 3% F
Risk Adjusted Return 14.82% 27% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.